1st Quarter - Report

ASSOCIATION OF NATIONAL ADVERTISERS, INC. for ASSOCIATION OF NATIONAL ADVERTISERS, INC.

Firm
Client
Income
—
Expenses
$260,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Tobacco TOB

Food and Drug Administration proposed rule on Required Warnings for Cigarette Packages and Advertisements

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Federal Trade Commission (FTC)

Computer Industry CPI

H.R. 611 - Building Effective Strategies to Promote Responsibility Accountability Choice Transparency Innovation Consumer Expectations and Safeguards Act (BEST PRACTICES Act), regulating the collection and use of consumer information in both the online and offline environment H.R. 654 - Do Not Track Me Online Act, establishing a online opt-out mechanism that allows consumers to prevent the collection or use of information relating to their online activity and other personal information Comments to Department of Commerce on its report entitled "Commercial Data Privacy and Innovation in the Internet Economy: A Dynamic Policy Framework" Comments to Federal Trade Commission on its report entitled "Protecting Consumer Privacy in an Era of Rapid Change: A Proposed Framework for Businesses and Policymakers"

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 654 (112th), H.R. 611 (112th)

Taxation/Internal Revenue Code TAX

H.R. 722 - Say No To Drug Ads Act, to end the tax deduction for expenses of advertising prescription drugs S. 174 - Healthy Lifestyles and Prevention America Act (HeLP America Act), to end the tax deduction for expenses of advertising tobacco products

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Federal Trade Commission (FTC); SENATE

Bills named: H.R. 722 (112th), S. 174 (112th)

Consumer Issues/Safety/Products CSP

The organization of the Consumer Financial Protection Bureau as it relates to the authority of the FTC and its role over the advertising industry

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: Federal Trade Commission (FTC); SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Beverage Industry BEV

Proposals to establish that states have primary regulatory authority over alcohol beverage products sold within their borders

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Food Industry (safety, labeling, etc.) FOO

S. 174 - Healthy Lifestyles and Prevention America Act (HeLP America Act), provisions to restore FTC rulemaking authority over advertsing to children Interagency Working Group study and recommendations on marketing of food to children 17 years old and younger

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: Federal Trade Commission (FTC); Commerce, Dept of (DOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 174 (112th)

Pharmacy PHA

Proposals to require a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: SENATE; Commerce, Dept of (DOC); Federal Trade Commission (FTC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Communications/Broadcasting/Radio/TV COM

FCC NOI on blocking technolgoies and content ratings for television commercials FCC NOI on protecting children in an evolving media landscape FCC rulemaking on regulating the volume in television commercials

LobbyistCovered position, as disclosed
DAVID P BUZBY —
DANIEL L JAFFE —
KEITH A SCARBOROUGH —

Contacted: Commerce, Dept of (DOC); SENATE; Food & Drug Administration (FDA); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.